Comparative effectiveness of nirmatrelvir/ritonavir versus sotrovimab and molnupiravir for preventing severe COVID-19 outcomes in non-hospitalised high-risk patients during Omicron waves: observational cohort study using the OpenSAFELY platform. (2023)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.lanepe.2023.100741
PubMed Identifier: 37927438
Publication URI: http://europepmc.org/abstract/MED/37927438
Type: Journal Article/Review
Volume: 34
Parent Publication: The Lancet regional health. Europe
ISSN: 2666-7762